Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EPHA4 |
| Upstream (Parents) |
|---|
| (<<) ARL4C → EPHA4 |
| (<<) CDK6 → EPHA4 |
| (<<) CKB → EPHA4 |
| (<<) CRTC1 → EPHA4 |
| (<<) DMPK → EPHA4 |
| (<<) FOSL1 → EPHA4 |
| (<<) FZD7 → EPHA4 |
| (<<) GBP2 → EPHA4 |
| (<<) HOXA3 → EPHA4 |
| (<<) JAG1 → EPHA4 |
| (<<) KRT6B → EPHA4 |
| (<<) MMP19 → EPHA4 |
| (<<) NUPR1 → EPHA4 |
| (<<) PAK6 → EPHA4 |
| (<<) PLCD1 → EPHA4 |
| (<<) PPP3CA → EPHA4 |
| (<<) PSORS1C2 → EPHA4 |
| (<<) RASSF5 → EPHA4 |
| (<<) RNASE7 → EPHA4 |
| (<<) SEMA3A → EPHA4 |
| (<<) TNFRSF1A → EPHA4 |
| (<<) TYRO3 → EPHA4 |
| (<<) WNT5B → EPHA4 |
| Downstream (Children) |
|---|
| EPHA4 → ADORA2B (>>) |
| EPHA4 → CLCA4 (>>) |
| EPHA4 → DYRK1A (>>) |
| EPHA4 → GOT2 (>>) |
| EPHA4 → MST1R (>>) |
| EPHA4 → MT3 (>>) |
| EPHA4 → NPC1 (>>) |
| EPHA4 → PI3 (>>) |
| EPHA4 → PLCG1 (>>) |
| EPHA4 → SLC6A14 (>>) |
| EPHA4 → SPINK5 (>>) |
| EPHA4 → ZNF750 (>>) |
